Rajen Dalal, Bill Green, Rian de Jonge, Robert Weist, Michael Dunn, John Mendlein, Robert Strausberg, David Ebsworth, Amy Romero-Gasman | GenomeWeb

Rajen Dalal, president and CEO of Guava Technologies, has joined Ciphergen Biosystems’ board of directors. Bill Green, president and CEO of Stanford Research Systems, has resigned from the board of the company.

Following the acquisition of Semaia Pharmaceuticals by Hybrigenics (see p.1), Rian de Jonge, former CEO of Utrecht, the Netherlands-based Semaia, has become executive VP for research and development at Paris-based Hybrigenics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.